CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Macrogen Company Snapshot
Macrogen operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Macrogen with three other companies in this sector in South Korea: Seoulin Bioscience Company Limited (2018 sales of 49.88 billion Korean Won [US$43.84 million] of which 92% was Biotechnology), Medipost Co Ltd (44.38 billion Korean Won [US$39.01 million] of which 47% was Umbilical Cord Blood), and NanoenTek Incorporated (25.80 billion Korean Won [US$22.68 million] of which 54% was Diagnosis).

Sales Analysis. During the year ended December of 2018, sales at Macrogen were 110.30 billion Korean Won (US$96.95 million). This is an increase of 8.4% versus 2017, when the company's sales were 101.79 billion Korean Won. This was the fifth consecutive year of sales increases at Macrogen (and since 2013, sales have increased a total of 129%). Sales of Others saw an increase that was more than double the company's growth rate: sales were up 314.2% in 2018, from 2.19 billion Korean Won to 9.07 billion Korean Won. Macrogen also saw significant increases in sales in Genome Application (up 14.4% to 6.37 billion Korean Won) . Not all segments of Macrogen experienced an increase in sales in 2018: sales of Ces fell 0.1% to 32.42 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Macrogen
  Stock Performance Chart for Macrogen
 
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 35,200
(Figures in Korean Won)
1 Week 2.5%   13 Weeks -3.0%  
4 Weeks 19.7%   52 Weeks -25.1%  
 
Macrogen Key Data:
  Ticker: 038290 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 110,298,578,352
(Year Ending Jan 2019).
Employees: 310
  Currency: Korean Won Market Cap: 352,683,372,800
  Fiscal Yr Ends: December Shares Outstanding: 10,019,414
  Share Type: Common Closely Held Shares: 1,087,620
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.